OR-1855 (Standard)

Overview

OR-1855 (Standard) is an analytical standard of OR-1855 ( HY-W050000 ). This product is intended for research and analytical applications. OR-1855 , an active metabolite of Levosimendan ( HY-14286 ), has effect on myometrial contractility. OR-1855 exerts anti-inflammatory effects by inhibiting IL-1β-induced ROS formation and NAD(P)H oxidase-dependent superoxide radical generation in HUVECs. OR-1855 inhibits IL-1β-induced phosphorylation p38 MAPK , ERK1/2 , c-Jun and JNK in HUVECs. OR-1855 can be used for the study of inflammation.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Others | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Reactive Oxygen Species (ROS) | Products > Signaling Pathways > ERK | Products > Signaling Pathways > p38 MAPK | Products > Signaling Pathways > Drug Metabolite | Products > Signaling Pathways > Reference Standards

Product Information

• Catalog No.: HY-W050000R
• CAS No.: 101328-85-2
• Molecular Formula: C11H13N3O
• Molecular Weight: 203.25
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source